Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stadler

Showing results (571-580 of 724) with videos related to

Pageof 73
Sort By:
Investigational New Drugs|March 4, 2006
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinomaAmy C Peterson, Helena Harlin, Theodore Karrison, et al.
The Prostate|May 13, 2011
Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancersRussell Z Szmulewitz, Elizabeth Chung, Hikmat Al-Ahmadie, et al.
The Prostate|October 24, 2015
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium StudyEdwin M Posadas, Rafi S Ahmed, Theodore Karrison, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2014
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cellsAlexander Eggel, Günther Baravalle, Gabriel Hobi, et al.
Chemical Communications (Cambridge, England)|June 20, 2023
Unusual selectivity in the ring-opening of γ-valerolactone oxide by aminesZahra Mazloomi, Fabian Kallmeier, Sarah Kirchhecker, et al.
European Journal of Immunology|May 6, 1999
Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoidM P Horn, T Gerster, B Ochensberger, et al.
Cancer|February 1, 2021
Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancerRichard T Lee, Nancy Kwon, Jimin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentMichael L Maitland, Kristen E Kasza, Theodore Karrison, et al.
Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Pageof 73

Showing results (571-580 of 724) with videos related to

Sort By:
Pageof 73
Investigational New Drugs|March 4, 2006
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinomaAmy C Peterson, Helena Harlin, Theodore Karrison, et al.
The Prostate|May 13, 2011
Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancersRussell Z Szmulewitz, Elizabeth Chung, Hikmat Al-Ahmadie, et al.
The Prostate|October 24, 2015
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium StudyEdwin M Posadas, Rafi S Ahmed, Theodore Karrison, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2014
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cellsAlexander Eggel, Günther Baravalle, Gabriel Hobi, et al.
Chemical Communications (Cambridge, England)|June 20, 2023
Unusual selectivity in the ring-opening of γ-valerolactone oxide by aminesZahra Mazloomi, Fabian Kallmeier, Sarah Kirchhecker, et al.
European Journal of Immunology|May 6, 1999
Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoidM P Horn, T Gerster, B Ochensberger, et al.
Cancer|February 1, 2021
Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancerRichard T Lee, Nancy Kwon, Jimin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentMichael L Maitland, Kristen E Kasza, Theodore Karrison, et al.
Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM modelR Chugh, K A Griffith, E J Davis, et al.
Pageof 73